What is New Objective?
New Objective is a specialized provider of advanced PicoTip technologies, crucial for global life science research utilizing mass spectrometry. With a legacy spanning over 25 years, the company offers a comprehensive suite of products, including nanospray emitters, columns, and sources, engineered for high-performance proteomics workflows. Their proprietary solutions, such as PicoChip and FlowChip, are designed for both nanoflow and microflow applications, ensuring enhanced reproducibility and operational efficiency for researchers in over 40 countries. These contributions have been cited in more than 10,000 scientific publications, highlighting the company's impact on the scientific community.
How much funding has New Objective raised?
New Objective has raised a total of $375K across 2 funding rounds:
Debt
$150K
Debt
$225K
Debt (2020): $150K with participation from PPP
Debt (2021): $225K led by PPP
What's next for New Objective?
The recent major strategic investment signals a new phase of growth and development for New Objective, likely enabling further innovation in their PicoTip technology portfolio and expansion into new markets. This substantial backing, within the context of large-scale late-stage funding, suggests a strong market position and investor confidence in the company's trajectory. Future endeavors may focus on scaling production, enhancing R&D for next-generation mass spectrometry tools, and broadening their global reach to support an even larger segment of the life science research ecosystem.
See full New Objective company page
